Pharmaceutical & Biotech
Catalent Amps Up Contract Biological Manufacturing Capacity Plans to $200 million, an Industrial Info Market Brief
On the heels of an already ambitious $100 million expansion plan, Catalent Incorporated has upped the ante by another $100 million.
Reports related to this article:
Project(s): View 3 related projects in PECWeb
Plant(s): View 1 related plant in PECWeb
On the heels of an already ambitious $100 million expansion plan, Catalent Incorporated has upped the ante by another $100 million. Catalent will invest $100 million in its bulk biological site in Madison, Wisconsin, with the other $100 million going to the Bloomington, Indiana, site. The company bought the 875,000-square-foot Blooomington site last year from Cook Pharmica for $950 million to further expand into biological contract manufacturing.
/news/article.jsp
false
Want More IIR News?
Make us a Preferred Source on Google to see more of us when you search.
Add Us On GoogleAsk Us
Have a question for our staff?
Submit a question and one of our experts will be happy to assist you.
Forecasts & Analytical Solutions
Where global project and asset data meets advanced analytics for smarter market sizing and forecasting.
Learn MoreRelated Articles
-
Novo Nordisk Spends $11 Billion to Make More Weight Loss Dru...February 15, 2024
-
EU Adds New COVID-19 Manufacturing CapacitySeptember 07, 2021
-
ISPE Names the 2017 Pharmaceutical Facility of the Year Cate...February 07, 2017
Industrial Project Opportunity Database and Project Leads
Get access to verified capital and maintenance project leads to power your growth.
Learn MoreIndustry Intel
-
From Data to Decisions: How IIR Energy Helps Navigate Market VolatilityOn-Demand Podcast / Nov. 18, 2025
-
Navigating the Hydrogen Horizon: Trends in Blue and Green EnergyOn-Demand Podcast / Nov. 3, 2025
-
ESG Trends & Challenges in Latin AmericaOn-Demand Podcast / Nov. 3, 2025
-
2025 European Transportation & Biofuels Spending OutlookOn-Demand Podcast / Oct. 27, 2025
-
2025 Global Oil & Gas Project Spending OutlookOn-Demand Podcast / Oct. 24, 2025
